Keyword: University of Pennsylvania
Antimalarial drugs known as chloroquines play a role in inhibiting cancer cell growth by targeting the enzyme PPT1, researchers discovered.
The pact tasks Weissmann’s UPenn lab with taking vaccines against up to 10 infectious diseases through to the completion of IND-enabling studies.
Recent biotech developments include improved viral delivery vehicles for gene therapy and compounds that cripple resistant bacteria.
Two separate teams used modified versions of CRISPR-Cas9 to correct rare but lethal inherited liver diseases.
Recent biotech discoveries include a sensory protein at the heart of hearing and new insights into how CAR-T design affects cancer treatments.
PARP inhibitors prevent the misplacement of a specific protein that has been implicated in ALS, new research shows.
T-cell developer Tmunity named Immunocore’s Christina Coughlin as CMO as it preps for early cancer studies after raising $135 million in VC funding.
New discoveries in biotech include a coated capsule for delivering insulin and inherited gene mutations that may portend pancreatic cancer risk.
Biotech developments over the past week include using circulating RNA to predict preemie births and a new way to free up stiffened heart muscle.
The cash sets ex-Novartis executive Usman “Oz” Azam up to hustle Tmunity's pipeline of T cell-based immunotherapies through clinical development.